Skip to content

Prehab FAI - Prehabilitation for patients undergoing arthroscopic hip surgery for Femoroacetabular impingement syndrome

Prehabilitation for patients undergoing surgery for Femoroacetabular Impingement Syndrome - a feasibility study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15371248
Enrollment
16
Registered
2023-03-09
Start date
2023-04-21
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoroacetabular impingement syndrome Musculoskeletal Diseases

Interventions

Current interventions as of 09/04/2024: Randomisation & Blinding Once patients are allocated to one of the two groups (prehabilitation or standard care), all baseline data will be obtained. This wil
2) audit trails for tracking data manipulation and export procedures
3) automated export procedures for seamless data downloads to common statistical packages
and 4) procedures for data integration and interoperability with external sources. Blinding participants and clinicians delivering interventions will not be possible as both will be aware of the inter

Sponsors

Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients referred to Cambridge Young Adult Hip service (aged 16-50 years), undergoing hip arthroscopy for Femoroacetabular Impingement Syndrome.

Exclusion criteria

Exclusion criteria: 1. Previous hip disease such as Perthe’s, Slipped upper femoral epiphysis or avascular necrosis 2. Participants who are unable to give full written consent. 3. Pre-existing neuromuscular conditions like Motor neuron disease or Multiple sclerosis. 4. History of any previous hip surgery 5. History of any previous hip arthroscopies

Design outcomes

Primary

MeasureTime frame
The iHOT-12 is a patient-reported outcome of Quality of Life (QoL) and will be the planned primary outcome measure for this study. This will be measured at baseline, Pre-op (after prehabilitation), 6 weeks, 6 months and 12 months post-op. Added 22/08/2023: Study follow-up points will be +/- 4 weeks to accommodate flexibility in clinic appointments within the NHS: Upon further consideration of the current situation and waiting times within the NHS, having a rigid follow-up point would not be feasible. Therefore, the follow-up points are kept flexible, but within a reasonable duration, so this does not affect the quality of the study. Patient-reported outcome measures will be completed digitally via online surveys at baseline and all other follow-up points (at pre-op, 6 weeks,6 months and 12 months post-op) using REDCap. A link to the online outcome measures survey with instructions will be emailed to participants for completion at the above follow-up points. If participants forget to complete the outcome questionnaire on the required day, a reminder to complete it will be sent on two more occasions after the deadline to facilitate compliance.

Secondary

MeasureTime frame
1. Hip muscle strength using a handheld dynamometer will be measured at baseline, Pre-op (after prehabilitation), 6 weeks and 6 months post-op. 2. The Star excursion balance test is a reliable measure to assess dynamic postural control and proprioception and will be measured at baseline, Pre-op (after prehabilitation), 6 weeks and 6 months post-op. 3. Pain will be measured using Brief Pain Inventory-short form (BPI) and will be measured at baseline, Pre-op (after prehabilitation), 6 weeks, 6 months and 12 months post-op. 4. Anxiety and depression will be measured using Hospital Anxiety and Depression Scale (HADS) at baseline, Pre-op (after prehabilitation), 6 weeks, 6 months and 12 months post-op. 5. Patient’s Global Impression of Change (PGIC) will be used to gather a patient’s perception of change after intervention and will be measured at baseline, Pre-op (after prehabilitation), 6 weeks, 6 months and 12 months post-op. Added 22/08/2023: Study follow-up points will be +/- 4 weeks to accommodate flexibility in clinic appointments within the NHS: Upon further consideration of the current situation and waiting times within the NHS, having a rigid follow-up point would not be feasible. Therefore, the follow-up points are kept flexible, but within a reasonable duration, so this does not affect the quality of the study. Patient-reported outcome measures will be completed digitally via online surveys at baseline and all other follow-up points (at pre-op, 6 weeks,6 months and 12 months post-op) using REDCap. A link to the online outcome measures survey with instructions will be emailed to participants for completion at the above follow-up points. If participants forget to complete the outcome questionnaire on the required day, a reminder to complete it will be sent on two more occasions after the deadline to facilitate compliance.

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026